We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DAVA Will Market Impax's Generic OxyContin Products
DAVA Will Market Impax's Generic OxyContin Products
November 15, 2005
Impax Laboratories has signed a supply and distribution deal under which DAVA Pharmaceuticals will market Impax’s oxycodone HCl extended-release tablets in the U.S. and Puerto Rico.